Mutations in Complement Factor I Predispose to Development of Atypical Hemolytic Uremic Syndrome
David Kavanagh, Elizabeth J. Kemp, Elizabeth Mayland et al. · Journal of the American Society of Nephrology · 2005
Mutations in the plasma complement regulator factor H (CFH) and the transmembrane complement regulator membrane co-factor protein (MCP) have been shown to predispose to atypical hemolytic uremic syndrome (HUS). Both of these proteins act as co-factors for complement factor I (IF). IF is a highly specific serine protease that cleaves the alpha-chains of C3b and C4b and thus downregulates activation of both the classical and the alternative complement pathways. This study looked for IF mutations in a panel of 76 patients with HUS. Mutations were detected in two patients, both of whom had reduced serum IF levels. A heterozygous bp change, c.463 G>A, which results in a premature stop codon (W127X), was found in one, and in the other, a heterozygous single base pair deletion in exon 7 (del 922C) was detected. Both patients had a history of recurrent HUS after transplantation. This is in accordance with the high rate of recurrence in patients with CFH mutations. Patients who are reported to have mutations in MCP, by contrast, do not have recurrence after transplantation. As with CFH- and MCP-associated HUS, there was incomplete penetrance in the family of one of the affected individuals. This study provides further evidence that atypical HUS is a disease of complement dysregulation.
Cited by 475 works. doi:10.1681/asn.2005010103
Authors
- David Kavanagh
- Elizabeth J. Kemp
- Elizabeth Mayland
- Robin J. Winney
- Jeremy S. Duffield
- Graham L. Warwick
- Anna Richards
- Roy Ward
- Judith A. Goodship
- Timothy H.J. Goodship
References
- Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.
- Genetic studies into inherited and sporadic hemolytic uremic syndrome
- Increased Susceptibility to Infection Associated with Abnormalities of Complement-Mediated Functions and of the Third Component of Complement (C3)
- Complement C3 Variant and the Risk of Age-Related Macular Degeneration
- Factor H Mutations in Hemolytic Uremic Syndrome Cluster in Exons 18–20, a Domain Important for Host Cell Recognition
- The Molecular Basis of Familial Hemolytic Uremic Syndrome
- Clustering of Missense Mutations in the C-Terminal Region of Factor H in Atypical Hemolytic Uremic Syndrome
- Mutations in Complement Factor I Predispose to Development of Atypical Hemolytic Uremic Syndrome
- Membrane Cofactor Protein (MCP or CD46): Newest Member of the Regulators of Complement Activation Gene Cluster
- HOMOZYGOUS DEFICIENCY OF C3 IN A PATIENT WITH REPEATED INFECTIONS